A woman in King County, Washington, succumbed to a rare blood clotting syndrome after receiving the Johnson & Johnson Covid-19 vaccine. This is the first death of its kind in the state, according to a statement posted online by Public Health — Seattle & King County.
Jessica Berg Wilson, a 37-year-old mother of two, died on September 7 from COVID-19 vaccine-induced thrombotic thrombocytopenia, known as TTS. It is a rare and potentially fatal clotting condition that has been linked with the J&J vaccine. Only three other cases of the condition that resulted in death have been identified across the country.
Blood Clots Can Be Treated
The diagnosis was validated by the US Centers for Disease Control and Prevention’s Clinical Immunization Safety Assessment Project, according to Seattle and King County. The CDC and the US Food and Drug Administration suggested a suspension in the use of the J&J Covid-19 vaccine earlier this year after a small number of reports of blood clots among patients who had received the Johnson & Johnson vaccine, the majority of whom were women under the age of 50. The Agency eventually concluded that the vaccine’s advantages outweighed the dangers of contracting COVID-19.
Read Also: IRS Update:- Treasury Secretary Janet Yellen Supports IRS Looking On Bank Accounts Of Transactions Above $600
Only 38 of the 12.5 million individuals who received the J&J vaccine reported having the same complications as of July 8, and the vast majority of them recovered. According to Dr. Chris Spitters, the health officer for Snohomish County, the risk of developing blood clots from the J&J vaccine is lower than the risk of severe complications from vaccines for other diseases, which they routinely accept, since it can be treated with anticoagulants other than heparin.
Symptoms of TTS
According to the CDC, those who received the Johnson & Johnson vaccine should watch for signs of a blood clot with low platelets for several weeks following vaccination and seek medical attention promptly if they notice any. Severe or chronic headaches or blurred vision, shortness of breath, chest pain, leg swelling, severe abdominal pain, and fast bruising or tiny blood spots under the skin beyond the injection site are some of the symptoms. Anticoagulants other than heparin can be used to treat it.
Johnson & Johnson assured the safety and protection of every person who gets one of its products is the company’s top priority. It claims that any adverse incident report involving people receiving the vaccine, as well as its own assessment of the information, is shared with health authorities worldwide.
TTS has also been related to AstraZeneca’s coronavirus vaccination, which is banned in the US but widely utilized in other countries.